Dorthe B. Berthelsen
portal.findresearcher.sdu.dk
0000-0002-9300-7281
SDU
16 papers found
Refreshing results…
‘I couldn’t carry on taking a drug like that’: a qualitative study of patient perspectives on side effects from rheumatology drugs
"I couldn't carry on taking a drug like that"
OMERACT Core outcome measurement set for shared decision making in rheumatic and musculoskeletal conditions: a scoping review to identify candidate instruments
Generating a list of potentially important contextual factors covering randomized trials, cohorts, and measurement property studies: An OMERACT initiative
Consensus on the definitions and descriptions of the domains of the OMERACT Core Outcome Set for shared decision making interventions in rheumatology trials
Evolving and evaluating the OMERACT fellows program: insights and implications from OMERACT 2023 fellows
Patient outcomes in longitudinal observational studies (POLOS) of rheumatoid arthritis: Determining the OMERACT core domain set
Stakeholder endorsement advancing the implementation of a patient-reported domain for harms in rheumatology clinical trials: Outcome of the OMERACT Safety Working Group
Comparison of Exercise Therapy, Non-Steroidal Anti-Inflammatory Drugs, and Opioids for Knee Osteoarthritis Pain: A Systematic Review and Network Meta-Analysis
Similar Effects of Exercise Therapy, Nonsteroidal Anti-inflammatory Drugs, and Opioids for Knee Osteoarthritis Pain: A Systematic Review with Network Meta-analysis
Perceived Benefits, Barriers, and Facilitators of a Digital Patient-Reported Outcomes Tool for Routine Diabetes Care: Protocol for a National, Multicenter, Mixed Methods Implementation Study
Perceived Benefits, Barriers, and Facilitators of a Digital Patient-Reported Outcomes Tool for Routine Diabetes Care: Protocol for a National, Multicenter, Mixed Methods Implementation Study (Preprint)
Harms Reported by Patients in Rheumatology Drug Trials: A Systematic Review of Randomized Trials in the Cochrane Library from an OMERACT Working Group
Controversy and Debate on Meta-epidemiology. Paper 1: Treatment effect sizes vary in randomized trials depending on the type of outcome measure
Controversy and Debate on Meta-epidemiology. Paper 3: Causal inference from meta-epidemiology: a reasonable goal, or wishful thinking?
Identifying Possible Outcome Domains from Existing Outcome Measures to Inform an OMERACT Core Domain Set for Safety in Rheumatology Trials
Missing publications? Search for publications with a matching author name.